-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Great news! Shijiazhuang No. 4 Pharmaceutical has been granted a patent for an invention.
Category:
Time：2020-04-26
Recently, good news came from the National Intellectual Property Administration: Shijiazhuang Sihua Pharmaceutical Co., Ltd. has been granted an invention patent for a method of preparing terbutaline sulfate, and has successfully obtained the invention patent certificate.
Recently, good news came from the National Intellectual Property Administration: Shijiazhuang Sihua Pharmaceutical Co., Ltd. has been granted an invention patent for a method of preparing terbutaline sulfate, and has successfully obtained the invention patent certificate.
This invention patent provides a preparation method for terbutaline sulfate that significantly reduces the complexity of post-reaction processing, eliminates the need to introduce water and inorganic salts, and yields a product with high purity. Moreover, distilling the product under acidic conditions markedly enhances terbutaline’s stability. Both the catalyst and the reaction solvent can be recycled, thereby reducing environmental burdens. This invention boasts high practical value and great potential for widespread application and promotion.
In recent years, Shijiazhuang No.4 Pharmaceutical has continuously strengthened its R&D and innovation efforts, further enhancing both the quantity and quality of its patents and achieving new breakthroughs, thereby providing robust technological support for the company’s high-quality development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license